ZyVersa Therapeutics Inc. (ZVSA)
NASDAQ: ZVSA
· Real-Time Price · USD
0.50
-0.02 (-3.47%)
At close: May 14, 2025, 3:59 PM
-3.47% (1D)
| Bid | 0.49 |
| Market Cap | 1.81M |
| Revenue (ttm) | 26.08K |
| Net Income (ttm) | -2.41B |
| EPS (ttm) | -8.48 |
| PE Ratio (ttm) | -0.06 |
| Forward PE | -0.01 |
| Analyst | Strong Buy |
| Ask | 0.51 |
| Volume | 150,133 |
| Avg. Volume (20D) | 3,643,461 |
| Open | 0.50 |
| Previous Close | 0.52 |
| Day's Range | 0.48 - 0.51 |
| 52-Week Range | 0.47 - 6.30 |
| Beta | 0.66 |
About ZVSA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ZVSA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ZVSA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
+24.24%
ZyVersa Therapeutics shares are trading higher aft...
Unlock content with
Pro Subscription
6 months ago
+39.56%
ZyVersa Therapeutics shares are trading higher after the company highlighted data showing the potential of inflammasome inhibition to protect pancreatic islet beta cells and attenuate progression from obesity to insulin resistance and type 2 diabetes.
